ALKBH5‐mediated m 6 A demethylation ameliorates extracellular matrix deposition in cutaneous pathological fibrosis
Clinical and Translational Medicine · 2024-09 · 14 (9)
DOI: 10.1002/ctm2.70016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 04.09.2024. Verfasst von Ruoqing Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. …. Hauptthemen laut MEDLINE: AlkB Homolog 5, RNA Demethylase, Extracellular Matrix, Fibrosis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Key Clinical Specialty, 'Two Hundred Talent' Program.
Abstract (Originalsprache)
Background
Elevated extracellular matrix (ECM) accumulation is a major contributing factor to the pathogenesis of fibrotic diseases. Recent studies have indicated that N6‐methyladenosine (m 6 A) RNA modification plays a pivotal role in modulating RNA stability and contribute to the initiation of various pathological conditions. Howbeit, the precise mechanism by which m 6 A influences ECM deposition remains unclear.
Methods
In this study, we used hypertrophic scars (HTSs) as a paradigm to investigate ECM‐related diseases. We focused on the role of ALKBH5‐mediated m 6 A demethylation within the pathological progression of HTSs and examined its correlation with clinical stages. The effects of ALKBH5 ablation on ECM components were studied both in vivo and in vitro. Downstream targets of ALKBH5, along with their underlying mechanisms, were identified using integrated high‐throughput analysis, RNA‐binding protein immunoprecipitation and RNA pull‐down assays. Furthermore, the therapeutic potential of exogenous ALKBH5 overexpression was evaluated in fibrotic scar models.
Results
ALKBH5 was decreased in fibroblasts derived from HTS lesions and was negatively correlated with their clinical stages. Importantly, ablation of ALKBH5 promoted the expression of COL3A1, COL1A1, and ELN, leading to pathological deposition and reconstruction of the ECM both in vivo and in vitro. From a therapeutic perspective, the exogenous overexpression of ALKBH5 significantly inhibited abnormal collagen deposition in fibrotic scar models. As determined by integrated high‐throughput analysis, key ECM components including COL3A1, COL1A1, and ELN are direct downstream targets of ALKBH5. By means of its mechanism, ALKBH5 inhibits the expression of COL3A1, COL1A1, and ELN by removing m 6 A from mRNAs, thereby decreasing their stability in a YTHDF1‐dependent manner.
Conclusions
Our study identified ALKBH5 as an endogenous suppressor of pathological ECM deposition, contributing to the development of a reprogrammed m6A‐targeted therapy for HTSs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China.
ORCID-Profile: Tao Zan
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Key Clinical Specialty
- 'Two Hundred Talent' Program
- 'Hengjie' Program of Shanghai Health Youth Talent Reward Foundation
- China Postdoctoral Science Foundation
Zitieren
APA
Xu, R., Yang, E., Liang, H., Luo, S., Liu, Y., Khoong, Y., Li, H., Huang, X., Zhao, Y., & Zan, T. (2024). ALKBH5‐mediated m 6 A demethylation ameliorates extracellular matrix deposition in cutaneous pathological fibrosis. Clinical and Translational Medicine, 14(9). https://doi.org/10.1002/ctm2.70016
Vancouver
Xu R, Yang E, Liang H, Luo S, Liu Y, Khoong Y, et al. ALKBH5‐mediated m 6 A demethylation ameliorates extracellular matrix deposition in cutaneous pathological fibrosis. Clinical and Translational Medicine. 2024;14(9). doi:10.1002/ctm2.70016
BibTeX
@article{Xu2024,
author = {Xu, Ruoqing and Yang, En and Liang, Hsin and Luo, Shenying and Liu, Yunhan and Khoong, Yimin and Li, Haizhou and Huang, Xin and Zhao, Yixuan and Zan, Tao},
title = {ALKBH5‐mediated m 6 A demethylation ameliorates extracellular matrix deposition in cutaneous pathological fibrosis},
journal = {Clinical and Translational Medicine},
year = {2024},
volume = {14},
number = {9},
doi = {10.1002/ctm2.70016}
}
EUVIMED